NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE263697 Query DataSets for GSE263697
Status Public on May 20, 2024
Title Glycolysis involved in transcription dysregulation through histone lactylation in T-lineage acute lymphoblastic leukemia II
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Tumor cells are known for excessive lactate production, due to Warburg effect, and transcriptional dysregulation. However, how lactate influences the epigenetic modifications at a genome-wide level and its impact on gene transcription in tumor cell remains unclear. Addressing this gap, we analyzed genome-wide modification of H3K18 lactylation (H3K18la) in T-cell acute lymphoblastic leukemia (T-ALL). Integrated analysis with histone modifications with established functions show the H3K18la is mainly involved in active regulation of gene transcription. We report increased lactate and H3K18la modification levels in T-ALL as compared to normal T cells. We observe clusters of H3K18la modifications in patterns reminiscent of super-enhancers. We show a notable shift of genome-wide H3K18la modification from T cell immunity in normal T cells to leukemogenesis in T-ALL, correlating with altered gene transcription profiles. By disrupting H3K18la modification, we uncover both synergetic and divergent changes between H3K18la and H3K27ac modifications, suggesting the H3K18la and H3K27ac modifications may have specific regulation mechanisms correspondingly. These findings expand our understanding of metabolic disruptions involvement in transcription dysregulation through epigenetic changes in T-ALL, and emphasize the collective importance of histone modifications in maintaining oncogenic epigenetic stability.
 
Overall design To explore the effects of H3K18la modifications on transcriptional regulation, we subjected JURKAT cells to RNA sequencing (RNA-Seq) across three experimental conditions: control (untreated), oxamate treatment, and combined oxamate and lactate treatment.
 
Contributor(s) Wu W, Sun H, Wang H, Wu X, Cui B, Zhao S, Fan R, Wang R, Zhong Y, Wang Y, Wu K, Chen X, Zheng L, shen S, Yin M, Liu Y
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 10, 2024
Last update date May 20, 2024
Contact name Wu Wenyan
E-mail(s) estheryan@sjtu.edu.cn
Organization name Shanghai Children's Medical Center
Street address 1678 Dongfang Road, Pudong New District, Shanghai
City Shanghai
ZIP/Postal code 200127
Country China
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (3)
GSM8196740 JURKAT, control
GSM8196741 JURKAT, oxamate
GSM8196742 JURKAT, oxamate and lactate
Relations
BioProject PRJNA1098754

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE263697_normalized_counts.txt.gz 140.1 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap